Enhancing Internal Limiting Membrane Inverted Flap Outcomes With Amniotic Solution for Chronic and Large Macular Holes.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41236118.
- Also identified by DOI 10.1097/IAE.0000000000004624 and PMC identifier 12637129.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This study assesses the effectiveness of a modified inverted internal limiting membrane flap technique combined with human amniotic membrane solution for treating large, chronic, and idiopathic conditions. Fourteen eyes from 14 patients underwent pars plana vitrectomy with a temporal internal limiting membrane flap technique and hAM application. Two methodologies for hAM preparation were compared: the direct injection of an hAM suspension and a refined method that used a vitrectomy probe to produce a homogeneous hAM solution. All eyes were tamponed with 20% sulfur hexafluoride. Postoperative outcomes showed significant improvements in best-corrected visual acuity and successful macular hole closure in all cases. The homogeneous hAM solution yielded superior anatomical and functional outcomes compared with the initial suspension method. It also showed better retinal layer integration without any adverse effects like displaced fragments or visual disturbances. This study highlights hAM solution as a promising supplement in macular hole surgery, enhancing flap stabilization and retinal regeneration. Larger studies are needed to confirm its long-term efficacy and safety.
Medical subject headings
- Retinal Perforations
- Vitrectomy
- Surgical Flaps
- Amnion
- Basement Membrane